Seeing is believing: NO therapy for glaucoma? Focus on "Role of nitric oxide in murine conventional outflow physiology"
- PMID: 26108667
- PMCID: PMC4537933
- DOI: 10.1152/ajpcell.00180.2015
Seeing is believing: NO therapy for glaucoma? Focus on "Role of nitric oxide in murine conventional outflow physiology"
Comment on
-
Role of nitric oxide in murine conventional outflow physiology.Am J Physiol Cell Physiol. 2015 Aug 15;309(4):C205-14. doi: 10.1152/ajpcell.00347.2014. Epub 2015 Jun 3. Am J Physiol Cell Physiol. 2015. PMID: 26040898 Free PMC article.
References
-
- Awadalla MS, Thapa SS, Hewitt AW, Craig JE, Burdon KP. Association of eNOS polymorphisms with primary angle-closure glaucoma. Invest Ophthalmol Vis Sci 54: 2108–2114, 2013. - PubMed
-
- Carta F, Supuran CT, Scozzafava A. Novel therapies for glaucoma: a patent review 2007–2011. Expert Opin Ther Patents 22: 79–88, 2012. - PubMed
-
- Ellis DZ. Guanylate cyclase activators, cell volume changes and IOP reduction. Cell Physiol Biochem 28: 1145–1154, 2011. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
